Implementation of Cardio-Oncology Training for Cardiology Fellows
- PMID: 34396296
- PMCID: PMC8352041
- DOI: 10.1016/j.jaccao.2020.11.003
Implementation of Cardio-Oncology Training for Cardiology Fellows
Keywords: cardio-oncology; cardiology; fellowship training.
Conflict of interest statement
Dr. Yang has received research funding from CSL Behring. Dr. Moslehi has served a consultant for Bristol Myers Squibb, Takeda, Deciphera, AstraZeneca, Nektar, Audentes Therapeutics, TripleGene, Boston Biomedical, ImmunoCore, Janssen, and Myovant; and is supported by grants from the National Institutes of Health (R01HL144146 and R01HL155990). Dr. Hayek is supported by the National Heart, Lung, and Blood Institute (1R01HL153384-01). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
References
-
- Miller K.D., Nogueira L., Mariotto A.B. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69:363–385. - PubMed
